Accendra Health Insider Pesicka Files Form 4 on Ownership Change
| Field | Detail |
|---|---|
| Company | Pesicka Edward A |
| Form Type | 4 |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-activity, form-4, ownership-change, executive-filing
TL;DR
**Accendra Health insider Pesicka filed a Form 4, signaling a change in his stock ownership.**
AI Summary
Edward A. Pesicka, an insider at Accendra Health Inc./VA/, filed a Form 4 on March 24, 2026, indicating changes in his beneficial ownership of the company's securities as of March 20, 2026. While the filing itself doesn't detail specific transactions (like buys or sells), it signals that an executive's holdings have changed. This matters to investors because insider activity, especially buying or selling, can sometimes be seen as a signal of management's confidence (or lack thereof) in the company's future prospects.
Why It Matters
This filing indicates a change in an executive's stake, which can influence investor perception of the company's health and future outlook.
Risk Assessment
Risk Level: low — A Form 4 filing itself is a routine disclosure and doesn't inherently carry high risk without knowing the specifics of the transaction.
Analyst Insight
A smart investor would note this filing and then seek out the full Form 4 document to understand the specific nature of the transaction (e.g., a buy, sell, or grant) and the number of shares involved, as this detail is crucial for interpreting the insider's sentiment.
Key Players & Entities
- Pesicka Edward A (person) — Reporting Person, insider at Accendra Health Inc./VA/
- Accendra Health Inc/VA/ (company) — Issuer of the securities
- 0001439487 (person) — CIK for Pesicka Edward A
- 0000075252 (company) — CIK for Accendra Health Inc/VA/
FAQ
What is the purpose of a Form 4 filing?
A Form 4, titled 'Statement of changes in beneficial ownership of securities,' is used to report changes in the ownership of company stock by company insiders (officers, directors, or beneficial owners of more than 10% of a class of the company's equity securities).
Who filed this specific Form 4?
This specific Form 4 was filed by Pesicka Edward A, identified as the 'Reporting' person, for Accendra Health Inc./VA/.
When was this Form 4 filed and what is the period of report?
The Form 4 was filed on March 24, 2026, and accepted on the same day. The 'Period of Report' for the changes in beneficial ownership was March 20, 2026.
What is the CIK number for Accendra Health Inc./VA/?
The CIK (Central Index Key) number for Accendra Health Inc./VA/ is 0000075252.
Does this filing indicate whether Edward A. Pesicka bought or sold shares?
This filing, as presented, only indicates that a Form 4 was filed, signifying 'changes in beneficial ownership of securities.' It does not provide the specific details of the transaction, such as whether shares were bought, sold, or granted, or the quantities involved. To determine that, one would need to review the full 'form4.html' or 'form4.xml' document mentioned in the filing.
Filing Stats: 612 words · 2 min read · ~2 pages · Grade level 8.3 · Accepted 2026-03-24 17:45:07
Filing Documents
- form4.html (4)
- form4.xml (4) — 3KB
- 0000075252-26-000016.txt ( ) — 5KB
From the Filing
SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Pesicka Edward A (Last) (First) (Middle) ACCENDRA HEALTH, INC. 4435 WATERFRONT DRIVE (Street) GLEN ALLEN VIRGINIA 23060 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol ACCENDRA HEALTH INC/VA/ [ ACH ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) President & CEO 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/20/2026 F 58,945 (1) D $ 2.03 1,090,477 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Edward A. Pesicka, by Rosemarie France POA 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)